ALS Untangled Series: Ep. 44 - Tamoxifen

Published: July 6, 2021, 8:06 p.m.

Tamoxifen is an FDA approved estrogen receptor modulator that is currently prescribed to treat breast cancer. Here we review surprising evidence that it could someday be an ALS treatment, including its mechanisms of action, pre-clinical data, cases, trials and risks.